Sex differences in endothelial function of aged hypertriglyceridemic rats – effect of atorvastatin treatment
Open Access
|Jan 2013References
- Bacova B, Radosinska J, Knezl V, Kolenova L, Weismann P, Navarova J, Baran-cik M, Mitasikova M and Tribulova N. (2010). Omega-3 fatty acids and ator-vastatin suppress ventricular f brillation inducibility in hypertriglyceride-mic rat hearts: implication of intercellular coupling protein, connexin-43.: 717-723.
- Baños G, Medina-Campos ON, Maldonado PD, Zamora J, Pérez I, Pavón N and Pedraza-Chaverrí J. (2005). Antioxidant enzymes in hypertensive and hy-pertriglyceridemic rats: ef ect of gender.: 45-57.
- Celermajer DS. (1997). Endothelial dysfunction: does it matter? Is it reversible?325-333.
- Gillespie CD, Keenan NL, Miner JB and Hong Y; Centers for Disease Control and Prevention (CDC). (2012). Screening for lipid disorders among adults-National Health and Nutrition Examination Survey, United States, 2005- 2008.(Suppl)26-31.
- Gupta R, Sharma KK, Gupta A, Agrawal A, Mohan I, Gupta VP, Khedar RS and Guptha S. (2012). Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5.11 - 1 6 .
- Libby P. (1995). Molecular bases of the acute coronary syndromes.2844-2850.
- Liebermann EH, Gerhard MD, Uehata A, Walsh BW, Selwyn AP, Ganz P, Yeung AC and Creager MA. (1994). Estrogen improves endothelium-dependent, f ow-mediated vasodilation in postmenopausal women.936-941.
- Liu MY, Hattori Y, Fukao M, Sato A, Sakuma I and Kanno M. (2001). Alterations in EDHF-mediated hyperpolarization and relaxation in mesenteric arteries of female rats in long-term def ciency of oestrogen and during oestrus cycle.1035-1046.
- Lush CW, Cepinskas G and Kvietys PR. (2000). LPS tolerance in human endo-thelial cells: reduced PMN adhesion, E-selectin expression, and NF-kappaB mobilization.H853-H861.
- Mazzone A, De Servi S, Ricevuti G, Mazzucchelli I, Fossati G, Pasotti D, Bramucci E, Angoli L, Marsico F and Specchia G. (1993). Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease.358-363.
- Mounier-Vehier C, Simon T, Guedj-Meynier D, Ferrini M, Ghannad E, Hubermann JP, Jullien G, Poncelet P, Achouba A, Quéré S and Guenoun M. (2012). Gender-related dif erences in the management of hypertension by cardiologists: the PARITE study.271-280.
- Pepine CJ, Nichols WW and Pauly D F. (2006). Estrogen and dif erent aspects of vascular disease in women and men.459-461.
- Pitsavos C, Skoumas I, Masoura C, Aznaouridis K, Papadimitriou L, Chryso-hoou C, Giotsas N, Toutouza M and Stefanadis C. (2008)Prevalence and determinants of coronary artery disease in males and females with familial combined hyperlipidaemia.402-407.
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). (1994).1383 -1389.
- Rosengren A, Wallentin L, Gitt AK, Behar S, Battler A and Hasdai D. (2004). Sex, age, and clinical presentation of acute coronary syndromes.663- 670.
- Sacks FM, Pfef er MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR and Braunwald E. (1996). The ef ect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Tr i a l inv es t i gat o rs .1001-1009.
- Sakabe K, Fukuda N, Fukuda Y, Wakayama K, Nada T, Morishita S, Shinohara H and Tamura Y.(2008). Gender dif erences in short-term ef ects of atorvas-tatin on lipid prof le, f brinolytic parameters, and endothelial function.182-188.
- Sima AV, Stancu CS and Simionescu M. (2009). Vascular endothelium in atherosclerosis.191-20 3.
- Sudhir K, Jennings GL, Funder JW and Komesarof PA. (1996). Estrogen enhances basal nitric oxide release in the forearm vasculature in perimeno-pausal women.330-334.
- Truong QA, Murphy SA, McCabe CH, Armani A and Cannon CP; TIMI Study Group. (2011). Benef t of intensive statin therapy in women: results from PROVE IT-TIMI 22.328-336.
- Vaughan CJ, Gotto AM Jr and Basson CT. (2000). The evolving role of statins in the management of atherosclerosis.1-10.
- Xi H, Akishita M, Nagai K, Yu W, Hasegawa H, Eto M, Kozaki K and Toba K. (2007). Potent free radical scavenger, edaravone, suppresses oxidative stress-induced endothelial damage and early atherosclerosis.281-289.
Language: English
Page range: 155 - 158
Published on: Jan 16, 2013
Published by: Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
In partnership with: Paradigm Publishing Services
Related subjects:
© 2013 Ruzena Sotnikova, Barbora Bacova, Jana Vlkovicova, Jana Navarova, Narcis Tribulova, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons License.